To include your compound in the COVID-19 Resource Center, submit it here.

Gilead misses Street, partners with MicroDose

Gilead Sciences Inc. (NASDAQ:GILD) reported 1Q11 financial results below the Street's estimates on Wednesday and announced a partnership with MicroDose Therapeutx Inc. (Monmouth Junction, N.J.) for

Read the full 260 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE